Guidelines for lupus anticoagulant testing in South Africa

Autor: Jessica Opie, J. Bailly, S. Louw, M. J. Coetzee, A. De Koker, Zivanai C. Chapanduka, Joachim Potgieter

Publikováno v: The Journal of Medical Laboratory Science and Technology of South Africa. 2:6-12

The antiphospholipid syndrome (APS) is a thrombophilic condition characterised by thromboses and/or adverse pregnancy outcomes. International criteria for the diagnosis of APS require that certain laboratory and clinical criteria are met. Lupus antic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::19af0ed1369815f38272b6ca658ec7c7
https://doi.org/10.36303/jmlstsa.2020.2.1.39

Crimean-Congo haemorrhagic fever presenting with undiagnosed chronic myeloid leukaemia

Autor: R. Swanepoel, M. J. Coetzee, André de Kock, Patricia A. Leman, Janusz T. Paweska, Lucille Blumberg

Publikováno v: Southern African Journal of Infectious Diseases. 32:142-144

A patient with Crimean-Congo haemorrhagic fever (CCHF) presented with a high white cell count and splenomegaly. Underlying chronic myeloid leukaemia was diagnosed. The management of this complex case was difficult, and the patient demised. This case

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::00a0afb14d91ca4b1433f400e6a15c3a
https://doi.org/10.1080/23120053.2017.1345493

Patient blood management: A solution for South Africa

Autor: Pieter Frederik Wessels, C Kassianides, Axel Hofmann, Hans Gombotz, C Hilton, G R M Bellairs, C A Barrett, Shannon Farmer, Vanitha Rambiritch, Jackie Thomson, C B Noel, P-L Wessels, M W Gibbs, Vernon J. Louw, L Boretti, E Verburgh, C Lundgren, M. J. Coetzee, F Schneider, A. Beeton, Aryeh Shander, Robert A. Wise, Johnny Mahlangu

Publikováno v: SAMJ: South African Medical Journal, Volume: 109, Issue: 7, Pages: 471-476, Published: JUL 2019

For more than 70 years the default therapy for anaemia and blood loss was mostly transfusion. Accumulating evidence demonstrates a significant dose-dependent relationship between transfusion and adverse outcomes. This and other transfusion-related ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbef7ca7eefe52836273747b462fa9bc
https://doi.org/10.7196/samj.2019.v109i7.13859

Recommendations for the management of sickle cell disease in South Africa

Autor: M. J. Coetzee, Atul Lakha, Mohammed R. Essop, N Alli, Vernon J. Louw, Janet Poole, Fatima Bassa, Vinitha Philip, Alan Davidson, Rosalind Wainwright, Nicolas Novitzky, Moosa Patel, Hassan Dawood Alli

Publikováno v: Europe PubMed Central
SAMJ: South African Medical Journal, Volume: 104, Issue: 11, Pages: 743-751, Published: NOV 2014

The spectrum of sickle cell disease (SCD) encompasses a heterogeneous group of disorders that include: (i) homozygous SCD (HbSS), also referred to as sickle cell anaemia; (ii) heterozygous SCD (HbAS), also referred to as sickle cell trait; and (iii)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d84bb9f22c6149adac72890782f1eb
https://pubmed.ncbi.nlm.nih.gov/25909112

Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A

Autor: Teresa M. Przytycka, Chava Kimchi-Sarfaty, David Lillicrap, Eric K. Moses, Zuben E. Sauna, Rosemary Schwyzer, Christopher A. Walsh, Mel Carless, John Blangero, Kathleen P. Pratt, Erica J. Martin, M. J. Coetzee, Rajendra Thejpal, Rathi V. Iyer, Rajalingam Raja, Lisa M. Miller-Jenkins, Kevin R. Viel, Neil C. Josephson, Kevin McRedmond, Tom E. Howard, Meera Chitlur, Shelley A. Cole, Kenneth Mann, Laura Almasy, Nadine Rapiti, Yasmin Goga, Christine L. Kempton, Natalia Rydz, Nigel S. Key, Janice S. Withycombe, Dana C. Matthews, Gouri Shankar Pandey, Chen Yanover, Jeanne M. Lusher, John C. Barrett, Elaine F. Reed, Joanne E. Curran, Cindy Lessinger, Rebecca Kruse-Jarres, Alexis A. Thompson, Afshin Ameri, Johnny Mahlangu, Saulius Butenas, Raymond G. Watts, David Stones, Amanda Krause, Susan H. Garfield, Craig M. Kessler, Vijaya L. Simhadri, Kavita Natarajan, Glenn F. Pierce

Publikováno v: Nature medicine

Neutralizing antibodies (inhibitors) to replacement factor VIII (FVIII, either plasma derived or recombinant) impair the effective management of hemophilia A. Individuals with hemophilia A due to major deletions of the FVIII gene (F8) lack antigenica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8dd2ea37f5d84455fe3be0240fbf75
https://pubmed.ncbi.nlm.nih.gov/24037092